About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Assessing Tolerability of Avonex Intramuscular Injections

Assessing Tolerability of Avonex Intramuscular Injections

NCT01641120·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Trinity Health Of New England

With

Biogen

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Between 18 - 65 years of age;
Confirmed diagnosis of Relapsing Remitting Multiple Sclerosis;
Currently being treated with Avonex® for at least 90 days;
Using 25 gauge needles for injection of Avonex® for at least 90 days;
Willing and able to complete study questionnaires; and
Provided informed consent to participate in this study

You may not be if

Diagnosis of Progressive Multiple Sclerosis;
History of recent illness or infection;
History of allergic reaction to Avonex®;
Any prior usage of a 30 gauge needle for administration of Avonex®;
Concurrent treatment with other immunomodulating therapies;
Pregnant or planning on becoming pregnant;
Nursing mothers; and
Unable to complete the requirements of the study

The record

StatusCompleted

PhaseNo phase

Taking part20

StartedMay 2012

UpdatedFeb 1, 2016

Conditions

Multiple Sclerosis

Where1

The Mandell Center for Multiple Sclerosis
Hartford, Connecticut, United States